News
CSPC will use its artificial-intelligence-driven, dual-engine efficient drug discovery platform to analyze the binding ...
AstraZeneca is paying CSPC Pharmaceutical Group $110 million up front to tap that China-based biotech’s artificial intelligence-driven technology for discovering and developing novel oral drugs.
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured ...
Davey D and Lina Girl discuss the hottest trends in technology from gaming to life-saving devices to apps that make you ...
The announcement builds on AZ's announcement earlier this year that it will invest $2.5 billion in an R&D facility in China, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results